PACIRA BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount
PACIRA BIOSCIENCES, INC. (PCRX) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount of -$6.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxSettlementsForeign · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. effective income tax rate reconciliation, tax settlement, foreign, amount for the quarter ending 2026-06-30 was -$6.40M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount 3 month |
|---|---|
| 2026-06-30 | -$6.40M 10-Q · filed 2026-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |